IPO postponements included a $500-million listing of IPSCO Tubulars, the U.S. subsidiary of Russian oil and gas pipe maker TMK; the $220-million flotation of Turkish fast-food chain operator TFI Tab Food Investments; and a $130-million listing by Argentine biotechnology firm Bioceres.
Medical technology company Motus GI, scheduled to list on Thursday, also did not price its IPO this week.
The biggest IPO to go ahead was the $437-million listing for Cactus Inc, which supplies wellheads and pressure control equipment.
Other listings included Victory Capital Holdings and Chinese wearable technology company Huami, although the Victory IPO priced at $13 per share, below its $17 to $19 indicated price range. Cardlytics priced on Thursday in a $70-million listing.
Listings for blank-check company Mudrick Capital and medical esthetics provider Evolus Inc went ahead, while Quintana Energy Services sold shares at $10, below its $12-$15 target range.
Of the seven listings this week, four were trading below their IPO prices on Friday.
"Investors will be looking at what companies and sectors will benefit from the impact of the recent tax reform and a higher interest rate environment relative to inflation fears that have disrupted the market," said Beyer.
This article was provided by Reuters.